Big Sioux Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-290
Closed -$1.06K – 317
2026
Q2
$1.06K Hold
290
– – ﹤0.01% 363
2026
Q1
$890 Hold
290
– – ﹤0.01% 368
2025
Q4
$1.19K Buy
+290
New +$1.44K ﹤0.01% 349

Other funds holding RXRX

Big Sioux Wealth Management's RXRX Position: Q3 2026 in Review

Big Sioux Wealth Management sold out of Recursion Pharmaceuticals (RXRX) in Q3 2026, closing a stake of 290 shares — an estimated $1.06K sold.

Big Sioux Wealth Management first reported a position in RXRX in Q4 2025 and held it in 3 quarters. The position peaked at $1.19K in Q4 2025. 353 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • Big Sioux Wealth Management reported no remaining Recursion Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Big Sioux Wealth Management sold 290 Recursion Pharmaceuticals shares in Q3 2026, an estimated $1.06K.
  • Big Sioux Wealth Management first reported a position in Recursion Pharmaceuticals in Q4 2025 and held it in 3 quarters.
  • Big Sioux Wealth Management's Recursion Pharmaceuticals position peaked at $1.19K in Q4 2025.
  • 353 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.